Cargando…

Serum Anti-CCNY Autoantibody Is an Independent Prognosis Indicator for Postoperative Patients with Early-Stage Nonsmall-Cell Lung Carcinoma

Cyclin Y (CCNY) is a novel cyclin and almost nothing is known about its role in human cancers. To investigate the clinical significance of serum anti-CCNY autoantibodies in nonsmall-cell lung carcinoma (NSCLC), the serum levels of CCNY protein in 264 patients with NSCLC, 103 patients with tuberculos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Li, Yue, Wentao, Teng, Yu, Zhang, Lina, Gu, Meng, Wang, Yue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789285/ https://www.ncbi.nlm.nih.gov/pubmed/24167380 http://dx.doi.org/10.1155/2013/935943

Ejemplares similares

Establishing a detection method for CCNY: a potentially significant clinical investigative marker in NSCLC patients
por: Ma, Li, et al.
Publicado: (2019)

CCNY Accelerates Cylcin E Expression to Regulate the Proliferation of Laryngeal Carcinoma Cells via MEK/ERK Signaling Pathway
por: Zhao, Xiaoting, et al.
Publicado: (2020)

CCNYL1, but Not CCNY, Cooperates with CDK16 to Regulate Spermatogenesis in Mouse
por: Zi, Zhenzhen, et al.
Publicado: (2015)

CCNI2 plays a promoting role in the progression of colorectal cancer
por: Lai, Dong‐Ming, et al.
Publicado: (2021)

The Candidate IBD Risk Gene CCNY Is Dispensable for Intestinal Epithelial Homeostasis
por: Molinas, Andrea, et al.
Publicado: (2021)

CCNI2 promotes the progression of human gastric cancer through HDGF
por: Chen, Wenchao, et al.
Publicado: (2021)

Combined detection of dickkopf-1 subtype classification autoantibodies as biomarkers for the diagnosis and prognosis of non-small cell lung cancer
por: Shen, Lei, et al.
Publicado: (2017)

Correction: CCNYL1, but Not CCNY, Cooperates with CDK16 to Regulate Spermatogenesis in Mouse
por: Zi, Zhenzhen, et al.
Publicado: (2019)

Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer
por: Pelosi, G, et al.
Publicado: (2003)

Phosphoregulation of the oncogenic protein regulator of cytokinesis 1 (PRC1) by the atypical CDK16/CCNY complex
por: Hernández-Ortega, Sara, et al.
Publicado: (2019)

The Implication of Serum Autoantibodies in Prognosis of Canine Mammary Tumors
por: Yuan, Stephen Hsien-Chi, et al.
Publicado: (2022)

Is surgery indicated for elderly patients with early stage nonsmall cell lung cancer, in the era of stereotactic body radiotherapy?
por: Nguyen, Nam P., et al.
Publicado: (2016)

Prognostic significance of circulating laminin gamma2 for early-stage non-small-cell lung cancer
por: Teng, Yu, et al.
Publicado: (2016)

The significant influence of having children on the postoperative prognosis of patients with nonsmall cell lung cancer: A propensity score‐matched analysis
por: Takamori, Shinkichi, et al.
Publicado: (2018)

Radiofrequency Ablation for Early-Stage Nonsmall Cell Lung Cancer
por: Hiraki, Takao, et al.
Publicado: (2014)

Cyclin I-like (CCNI2) is a cyclin-dependent kinase 5 (CDK5) activator and is involved in cell cycle regulation
por: Liu, Chengcheng, et al.
Publicado: (2017)

Interdisciplinary multimodality management of stage III nonsmall cell lung cancer
por: Huber, Rudolf M., et al.
Publicado: (2019)

Rare and frequent postoperative complications after combined pneumonectomy for nonsmall-cell lung cancer
por: Lyas, N, et al.
Publicado: (2013)

Pathologic Stage of Nonsmall Cell Lung Cancer Patients Presenting as Resectable Cases After Neoadjuvant Therapy Did Not Predict the Prognosis
por: Wu, Ching-Yang, et al.
Publicado: (2015)

Erratum: Cyclin I-like (CCNI2) is a cyclin-dependent kinase 5 (CDK5) activator and is involved in cell cycle regulation
por: Liu, Chengcheng, et al.
Publicado: (2017)

CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients
por: Kristiansen, G, et al.
Publicado: (2003)

Can Inflammatory and Nutritional Serum Markers Predict Chemotherapy Outcomes and Survival in Advanced Stage Nonsmall Cell Lung Cancer Patients?
por: Cehreli, Ruksan, et al.
Publicado: (2019)

Postoperative Regulatory T-Cells and Natural Killer Cells in Stage I Nonsmall Cell Lung Cancer Underwent Video-assisted Thoracoscopic Lobectomy or Thoracotomy
por: Zhang, Sai, et al.
Publicado: (2015)

Pathologic Stage of Nonsmall Cell Lung Cancer Patients Presenting as Resectable Cases After Neoadjuvant Therapy Did Not Predict the Prognosis: Erratum
Publicado: (2015)

Neoadjuvant chemotherapy and Avelumab in early stage resectable nonsmall cell lung cancer
por: Tfayli, Arafat, et al.
Publicado: (2020)

Pathologic Correlation of Serum Carcinoembryonic Antigen and Cytokeratin 19 Fragment in Resected Nonsmall Cell Lung Cancer
por: Lee, Seokkee, et al.
Publicado: (2013)

Risk factors of postoperative acute lung injury following lobectomy for nonsmall cell lung cancer
por: Kim, Hyun Jung, et al.
Publicado: (2019)

Coexistence of a novel CCNY-ALK and ATIC-ALK double-fusion in one patient with ALK-positive NSCLC and response to crizotinib: a case report
por: Wu, Xuan, et al.
Publicado: (2020)

Serum SP70 is a sensitive predictor of chemotherapy response in patients with advanced nonsmall cell lung cancer
por: Liu, Jingping, et al.
Publicado: (2018)

Serum Anti-Fumarate Hydratase Autoantibody as a Biomarker for Predicting Prognosis of Acute-on-Chronic Liver Failure
por: Wei, Linlin, et al.
Publicado: (2023)

No anti-ACTH autoantibody in serum of SARS patients
por: Li, Jing, et al.
Publicado: (2006)

Fisetin decreases TET1 activity and CCNY/CDK16 promoter 5hmC levels to inhibit the proliferation and invasion of renal cancer stem cell
por: Si, Yibing, et al.
Publicado: (2018)

Preoperative Total Serum Cholesterol and Patients' Survival in Resected Nonsmall Cell Lung Cancer
por: Tomita, Masaki, et al.
Publicado: (2012)

Is %ΔSUVmax a Useful Indicator of Survival in Patients with Advanced Nonsmall-Cell Lung Cancer?
por: Cistaro, Angelina, et al.
Publicado: (2013)

TFIIB-Related Factor 2 Is Associated with Poor Prognosis of Nonsmall Cell Lung Cancer Patients through Promoting Tumor Epithelial-Mesenchymal Transition
por: Tian, Yu, et al.
Publicado: (2014)

Roles of osteopontin and matrix metalloproteinase-7 in occurrence, progression, and prognosis of nonsmall cell lung cancer
por: Sun, Ying, et al.
Publicado: (2015)

PIK3CA gene mutation associated with poor prognosis of lung adenocarcinoma
por: Zhang, Lina, et al.
Publicado: (2013)

Pemetrexed-associated Ischemic Colitis in Nonsmall Cell Lung Cancer
por: Ye, Liang, et al.
Publicado: (2017)

Selective Depletion of Regulatory T Cell Subsets by Docetaxel Treatment in Patients with Nonsmall Cell Lung Cancer
por: Li, Jie-Yao, et al.
Publicado: (2014)

Macrophage Inhibitory Cytokine-1 as a Novel Diagnostic and Prognostic Biomarker in Stage I and II Nonsmall Cell Lung Cancer
por: Liu, Yu-Ning, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uav66dp6j9rehibt46gg0g2d3t